Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2018 Q2- Text added to 2018 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. senior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. senior Avg
|
New words:
AstraZeneca, autoimmune, cancer, EQUITYFOR, formula, hematopoietic, marrow, nominal, notably, open, opiate, precursor, release, releasing, unchanged
Removed:
adjustment, Astra, finance, ordinary, precision, preparing, suffering, Zeneca
Valuein 2018 Q2 filing- Value in 2018 Q3 filing
Original filings
Filing view